Trials / Completed
CompletedNCT04462562
Quantitative US for Evaluation of Hepatic Steatosis in NAFLD
The Diagnostic Performance Assessment of Quantitative Ultrasound Imaging Indices for Differentiating Hepatic Steatosis Grade in Patients With Non-alcoholic Fatty Liver Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 173 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate diagnostic performance of quantitative ultrasonographic parameters for the assessment of hepatic steatosis with find optimal cut-off values in patients with non-alcoholic fatty liver disease using magnetic resonance imaging proton density fat fraction (MRI-PDFF) and MR spectroscopy as the reference standard.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Quantitative US (Samsung Medison, RS85A) | In each patients, measurements of tissue attenuation imagine (TAI), tissue scatter-distribution imaging (TSI) parameters, hepatorenal index (EzHRI) will be performed |
Timeline
- Start date
- 2020-07-03
- Primary completion
- 2021-06-29
- Completion
- 2021-06-29
- First posted
- 2020-07-08
- Last updated
- 2022-03-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04462562. Inclusion in this directory is not an endorsement.